{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:01:45Z","timestamp":1791273705851,"version":"4.1.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.semcancer.2013.04.002","type":"journal-article","created":{"date-parts":[[2013,5,8]],"date-time":"2013-05-08T05:58:43Z","timestamp":1367992723000},"page":"422-430","source":"Crossref","is-referenced-by-count":51,"special_numbering":"PA","title":["Genetic aberrations of signaling pathways in lymphomagenesis: Revelations from next generation sequencing studies"],"prefix":"10.1016","volume":"23","author":[{"given":"Davide","family":"Rossi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Ciardullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Gaidano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semcancer.2013.04.002_bib0005","series-title":"WHO classification of tumours of haematopoietic abd lymphoid tissues","author":"Swerdlow","year":"2008"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0010","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1126\/science.1153629","article-title":"Oncogenic CARD11 mutations in human diffuse large B cell lymphoma","volume":"319","author":"Lenz","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0015","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nature07968","article-title":"Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma","volume":"459","author":"Compagno","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0020","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nature08638","article-title":"Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma","volume":"463","author":"Davis","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0025","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/ng.518","article-title":"Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin","volume":"42","author":"Morin","year":"2010","journal-title":"Nature Genetics"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0030","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ccr.2011.11.006","article-title":"Combined genetic inactivation of \u03b22-Microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma","volume":"20","author":"Challa-Malladi","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0035","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1084\/jem.20110921","article-title":"Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation","volume":"208","author":"Fabbri","year":"2011","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0040","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10351","article-title":"Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma","volume":"476","author":"Morin","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0045","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nature09671","article-title":"Oncogenically active MYD88 mutations in human lymphoma","volume":"470","author":"Ngo","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0050","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nature09730","article-title":"Inactivating mutations of acetyltransferase genes in B-cell lymphoma","volume":"471","author":"Pasqualucci","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0055","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/ng.892","article-title":"Analysis of the coding genome of diffuse large B-cell lymphoma","volume":"43","author":"Pasqualucci","year":"2011","journal-title":"Nature Genetics"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0060","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature10113","article-title":"Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia","volume":"475","author":"Puente","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0065","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/ng.1032","article-title":"Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia","volume":"44","author":"Quesada","year":"2011","journal-title":"Nature Genetics"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0070","doi-asserted-by":"crossref","first-page":"6904","DOI":"10.1182\/blood-2011-08-373159","article-title":"Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness","volume":"118","author":"Rossi","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0075","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1056\/NEJMoa1014209","article-title":"BRAF mutations in hairy-cell leukemia","volume":"364","author":"Tiacci","year":"2011","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0080","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1109016","article-title":"SF3B1 and other novel cancer genes in chronic lymphocytic leukemia","volume":"365","author":"Wang","year":"2011","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0085","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1084\/jem.20120910","article-title":"Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma","volume":"209","author":"Kiel","year":"2012","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0090","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1084\/jem.20120904","article-title":"The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development","volume":"209","author":"Rossi","year":"2012","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0095","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1182\/blood-2011-11-391474","article-title":"Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma","volume":"119","author":"Kridel","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0100","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1073\/pnas.1121343109","article-title":"Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing","volume":"109","author":"Lohr","year":"2012","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0105","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/ng.2468","article-title":"The genetic landscape of mutations in Burkitt lymphoma","volume":"44","author":"Love","year":"2012","journal-title":"Nature Genetics"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0110","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/ng.2469","article-title":"Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing","volume":"44","author":"Richter","year":"2012","journal-title":"Nature Genetics"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0115","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1182\/blood-2011-12-395673","article-title":"Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia","volume":"119","author":"Rossi","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0120","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nature11378","article-title":"Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics","volume":"490","author":"Schmitz","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0125","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1056\/NEJMoa1200710","article-title":"MYD88 L265P somatic mutation in Waldenstr\u00f6m's macroglobulinemia","volume":"367","author":"Treon","year":"2012","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0130","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2013-01-478834","article-title":"The E3 ubiquitin ligase UBR5 is recurrently mutated in mantle cell lymphoma","author":"Meissner","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0135","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1073\/pnas.1205299110","article-title":"Genetic heterogeneity of diffuse large B-cell lymphoma","volume":"110","author":"Zhang","year":"2013","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0140","doi-asserted-by":"crossref","first-page":"a003004","DOI":"10.1101\/cshperspect.a003004","article-title":"Antigen receptor signaling to NF-kappaB via CARMA1, BCL10, and MALT1","volume":"2","author":"Thome","year":"2010","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0145","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1182\/blood-2012-02-362624","article-title":"The B-cell receptor signaling pathway as a therapeutic target in CLL","volume":"120","author":"Woyach","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0150","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1600-065X.2008.00748.x","article-title":"Tyrosine kinases and their substrates in B lymphocytes","volume":"228","author":"Kurosaki","year":"2009","journal-title":"Immunological Reviews"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0155","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa012914","article-title":"The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma","volume":"346","author":"Rosenwald","year":"2002","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0160","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1126\/science.1071546","article-title":"B cell antigen receptor signaling: roles in cell development and disease","volume":"296","author":"Gauld","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0165","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/nri1944","article-title":"The CARMA1 signalosome links the signalling machinery of adaptive and innate immunity in lymphocytes","volume":"6","author":"Rawlings","year":"2006","journal-title":"Nature Reviews Immunology"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0170","doi-asserted-by":"crossref","first-page":"pe25","DOI":"10.1126\/scisignal.3134pe25","article-title":"B cell receptor signaling: picky about PI3Ks","volume":"3","author":"Limon","year":"2010","journal-title":"Science Signaling"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0175","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nri2507","article-title":"E and ID proteins branch out","volume":"9","author":"Kee","year":"2009","journal-title":"Nature Reviews Immunology"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0180","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nri3190","article-title":"Integration of B cell responses through Toll-like receptors and antigen receptors","volume":"12","author":"Rawlings","year":"2012","journal-title":"Nature Reviews Immunology"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0185","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.1182\/blood-2011-06-359166","article-title":"Alteration of BIRC3 and multiple other NF-\u03baB pathway genes in splenic marginal zone lymphoma","volume":"118","author":"Rossi","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0190","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3324\/haematol.2011.054080","article-title":"BCR and TLR signaling pathways are recurrently targeted by genetic changes in splenic marginal zone lymphomas","volume":"97","author":"Yan","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0195","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2012-09-457101","article-title":"Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstr\u00f6m's macroglobulinemia and related lymphoid neoplasms","author":"Varettoni","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0200","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1182\/blood-2012-09-454355","article-title":"MYD88 L265P in Waldenstr\u00f6m macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction","volume":"121","author":"Xu","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0205","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4049\/jimmunol.1203103","article-title":"MyD88: a critical adaptor protein in innate immunity signal transduction","volume":"190","author":"Warner","year":"2013","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0210","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/path.2789","article-title":"Notch signalling in T-cell lymphoblastic leukaemia\/lymphoma and other haematological malignancies","volume":"223","author":"Aster","year":"2011","journal-title":"Journal of Pathology"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0215","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1084\/jem.20111855","article-title":"Oncogenic and tumor suppressor functions of Notchin cancer: it's NOTCH what you think","volume":"208","author":"Lobry","year":"2011","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0220","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nrc2290","article-title":"FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation","volume":"8","author":"Welcker","year":"2008","journal-title":"Nature Reviews Cancer"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0225","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/ni1453","article-title":"Regulation of lymphocyte development by Notch signaling","volume":"8","author":"Tanigaki","year":"2007","journal-title":"Nature Immunology"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0230","doi-asserted-by":"crossref","first-page":"45031","DOI":"10.1074\/jbc.M105245200","article-title":"Role of Deltex-1 as a transcriptional regulator downstream of the Notch receptor","volume":"276","author":"Yamamoto","year":"2001","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0235","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nri2656","article-title":"The follicular versus marginal zone B lymphocyte cell fate decision","volume":"9","author":"Pillai","year":"2009","journal-title":"Nature Reviews Immunology"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0240","doi-asserted-by":"crossref","first-page":"15454","DOI":"10.1073\/pnas.0702891104","article-title":"Notch1 engagement by Delta-like-1 promotes differentiation of B lymphocytes to antibody-secreting cells","volume":"104","author":"Santos","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0245","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1074-7613(03)00029-3","article-title":"Regulation of marginal zone B cell development by MINT, a suppressor of Notch\/RBP-J signaling pathway","volume":"18","author":"Kuroda","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0250","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1182\/blood-2011-10-386144","article-title":"NOTCH1 mutations in CLL associated with trisomy 12","volume":"119","author":"Balatti","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0255","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3324\/haematol.2011.060129","article-title":"NOTCH1 mutations in +12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of +12 CLL","volume":"97","author":"Del Giudice","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0260","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/gcc.21972","article-title":"Different distribution of NOTCH1 mutations in chronic lymphocytic leukemia with isolated trisomy 12 or associated with other chromosomal alterations","volume":"51","author":"L\u00f3pez","year":"2012","journal-title":"Genes, Chromosomes and Cancer"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0265","doi-asserted-by":"crossref","first-page":"a000109","DOI":"10.1101\/cshperspect.a000109","article-title":"Oncogenic activation of NF-kappaB","volume":"2","author":"Staudt","year":"2010","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0270","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1182\/blood-2004-10-3898","article-title":"Splenic marginal zone lymphoma: proposal of new diagnostic and prognostic markers identified after tissue and cDNA microarray analysis","volume":"106","author":"Ruiz-Ballesteros","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0275","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1084\/jem.20090765","article-title":"A20 takes on tumors: tumor suppression by an ubiquitin-editing enzyme","volume":"206","author":"Malynn","year":"2009","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0280","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1172\/JCI25641","article-title":"cIAP2 is a ubiquitin proteinligase for BCL10 and is dysregulated in mucosa-associated lymphoid tissue lymphomas","volume":"116","author":"Hu","year":"2006","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0285","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3324\/haematol.2011.057109","article-title":"ATM and chronic lymphocytic leukemia: mutations, and not only deletions, matter","volume":"97","author":"Rossi","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0290","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nrc2694","article-title":"Signal integration by JNK and p38 MAPK pathways in cancer development","volume":"9","author":"Wagner","year":"2009","journal-title":"Nature Reviews Cancer"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0295","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2012.078071","article-title":"Constant activation of the RAF-MEK-ERK pathway as a diagnostic and therapeutic target in hairy cell leukemia","author":"Tiacci","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0300","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1182\/blood-2011-08-368209","article-title":"The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasms","volume":"119","author":"Arcaini","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0305","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1182\/blood-2011-08-371179","article-title":"Simple genetic diagnosis of hairy cell leukemia by sensitive detection of the BRAF-V600E mutation","volume":"119","author":"Tiacci","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0310","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1182\/blood-2011-09-379966","article-title":"Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia","volume":"119","author":"Rossi","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0315","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1182\/blood-2012-05-429282","article-title":"The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial","volume":"121","author":"Oscier","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0320","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1365-2141.2012.09155.x","article-title":"Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndrome","volume":"158","author":"Rossi","year":"2012","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0325","article-title":"NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome","author":"Villamor","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0330","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1600-065X.2012.01105.x","article-title":"Pathogenetic importance and therapeutic implications of NF-\u03baB in lymphoid malignancies","volume":"246","author":"Lim","year":"2012","journal-title":"Immunological Reviews"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0335","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1200\/JCO.2012.44.4281","article-title":"Targeting B-Cell receptor signaling for anticancer therapy: the Bruton's tyrosine kinase inhibitor ibrutinib induces impressive responses in B-cell malignancies","volume":"31","author":"Wiestner","year":"2013","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0340","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ccr.2012.05.024","article-title":"Exploiting synthetic lethality for the therapy of ABC diffuse large B cell lymphoma","volume":"21","author":"Yang","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0345","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/bjh.12201","article-title":"Rapid response of biallelic BRAF V600E mutated hairy cell leukaemia to low dose vemurafenib","volume":"161","author":"Follows","year":"2013","journal-title":"British Journal of Haematology"},{"key":"10.1016\/j.semcancer.2013.04.002_bib0350","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1056\/NEJMc1202124","article-title":"BRAF inhibition in refractory hairy-cell leukemia","volume":"366","author":"Dietrich","year":"2012","journal-title":"New England Journal of Medicine"}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X13000424?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X13000424?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T04:55:15Z","timestamp":1539665715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X13000424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":70,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S1044579X13000424"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2013.04.002","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}